你即將離開本站

並前往https://clinicaltrials.gov/ct2/show/NCT01939158

Immunogenicity and Safety Study of 1 and 2 Doses of ...

The purpose of this study is to compare the immediate and long term (up to 5 years) immunogenicity and safety of GSK Biologicals' MenACWY-TT vaccine when ...

確定！ 回上一頁

查詢 「GSK 104」的人也找了：

  1. MSD 104
    2.
  2. 諾華104
    3.
  3. gsk台灣裁員
    4.
  4. GSK 104
    5.
  5. gsk薪水ptt
    6.
  6. gsk流感疫苗
    7.
  7. gsk面試
    8.
  8. gsk台灣股票
    9.